Zivo Bioscience- Warrants (29/04/2026) Accounts Payable

The latest accounts payable for ZIVOW is $1.4M as of June 2026. That compares with $860K in the prior-year period — up 64.9% year over year. Investors often review this figure alongside Zivo Bioscience- Warrants (29/04/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ZIVOW's accounts payable moved from $860K to $1.4M — a 64.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Zivo Bioscience- Warrants (29/04/2026)'s operating scale or balance-sheet position.

A accounts payable figure of $1.4M for ZIVOW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ZIVOW's accounts payable ($1.4M), review year-over-year change from $860K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Zivo Bioscience- Warrants (29/04/2026)'s accounts payable against similar Consumer Discretionary names. You can also browse sector and industry screens on Stockcircle for a broader set of Consumer Discretionary companies and their key multiples and fundamentals.